Table 1 Description of survivors of young adult malignancies and matched controls cohort at diagnosis/referent dates
Survivors | Controls | |
|---|---|---|
(n = 20,911) | (n = 104,524) | |
Age, mean (SD) | 36 (6.3) | 36 (6.3) |
Median Follow-up Yearsa (IQR) | 13.5 (5.0,18.0) | 13.5 (5.0,18.0) |
Sex | ||
Male | 6,801 (32.3) | 33,997 (32.3) |
Female | 14,110 (67.7) | 70,527 (67.7) |
Malignancy Type | ||
Breast | 4581 (21.9) | - |
Gynecologicb | 2782 (13.3) | - |
Thyroid | 2388 (11.4) | - |
Melanoma | 2088 (10.0) | - |
Testicular | 1390 (6.6) | - |
Non-Hodgkin Lymphoma | 1277 (6.1) | - |
Hodgkin Lymphoma | 1072 (5.1) | - |
Urologic | 895 (4.3) | - |
Other | 887 (4.2) | - |
Colorectal | 785 (3.8) | - |
Head & Neck | 768 (3.7) | - |
Brain | 632 (3.0) | - |
Bone & Soft-tissue | 463 (2.2) | - |
Chest & Lung | 345 (1.6) | - |
Leukemia | 284 (1.4) | - |
Upper Gastrointestinal | 274 (1.3) | - |
Received Radiation | 6,517 (32.1) | |
Evidence of Recurrence | 1,199 (7.2) | - |
Diedc | 1,270 (6.1) | 1,600 (1.5) |
Income Quintile | ||
1 (lowest) | 3,983 (19.0) | 20,709 (19.8) |
2 | 4,082 (19.5) | 20,701 (19.8) |
3 | 4,176 (20.0) | 21,084 (20.2) |
4 | 4,425 (21.2) | 21,604 (20.7) |
5 (highest) | 4,245 (20.3) | 20,426 (19.5) |